The Pharmacological Frontier in Pediatric Heart Failure Management: Innovations and Prospects.
Cureus
; 16(1): e51913, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38196987
ABSTRACT
Pediatric heart failure, encompassing a diverse range of conditions, imposes a significant burden despite its relatively low incidence. The contemporary landscape, with infants constituting a majority of admissions, underscores the need for specialized attention. This editorial delves into the evolving pharmacological interventions for pediatric heart failure, emphasizing the nuances of managing congenital heart defects, genetic factors, and diverse etiologies. The goal is to contribute knowledge that addresses the unique needs of children and explores innovations promising to redefine care standards. The narrative navigates through the current state of pediatric heart failure management, unique considerations, emerging pharmacological innovations, precision medicine, addressing underlying causes, combination therapies, clinical trials, and ethical considerations. Each section contributes to a comprehensive understanding of the evolving landscape and sets the stage for potential future directions in pediatric heart failure care.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Aspects:
Ethics
Language:
En
Journal:
Cureus
Year:
2024
Document type:
Article
Country of publication:
United States